EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders

Enhancer of zeste homolog 2 (EZH2) is positively associated with poor clinical outcomes in a number of aggressive tumors. Recent studies have demonstrated that inhibition of EZH2 also suppressed the inflammatory response during sepsis. The present study aimed to investigate whether an inhibitor of E...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Dongyou, Wang, Zhiying, Yang, Yongan, Hu, Zhenjun, Luo, Ganping, Wang, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967880/
https://www.ncbi.nlm.nih.gov/pubmed/33747174
http://dx.doi.org/10.3892/etm.2021.9854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967880/
https://www.ncbi.nlm.nih.gov/pubmed/33747174
http://dx.doi.org/10.3892/etm.2021.9854

Ejemplares similares